NCT05617807

Brief Summary

Standard arthroscopy has been the gold standard for treatment of meniscus tears since the 1980's. The purpose of this study is to analyze the clinical outcomes of using the smaller diameter Nanoscope for partial menisectomy. The authors hypothesize that the Nanoscopic partial menisectomy patients will have less pain and return function faster than standard arthroscopy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2022

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 7, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 16, 2022

Completed
15 days until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

March 20, 2024

Status Verified

March 1, 2024

Enrollment Period

1.6 years

First QC Date

November 7, 2022

Last Update Submit

March 18, 2024

Conditions

Keywords

ArthroscopyMeniscusMeniscectomyNanoscopic

Outcome Measures

Primary Outcomes (2)

  • Functional Outcomes following partial meniscectomy: Knee Injury and Osteoarthritis Score

    We will be looking at functional outcomes following partial meniscectomy with the nanoscope compared to standard arthroscopy by looking at Knee Injury and Osteoarthritis Score (O -100 with higher being patients doing better functionally)

    6 weeks

  • Functional Outcomes Following Partial Meniscectomy: International Knee Documentation Committee Score

    We will be looking at functional outcomes following partial meniscectomy with the nanoscope compared to standard arthroscopy by looking at the International Knee Documentation Committee Score (0-100 with higher being patients doing better functionally)

    6 weeks

Secondary Outcomes (3)

  • Pain: Visual Analog Pain Score

    6 weeks

  • Narcotic Medication Use

    24 hours

  • Return to work

    6 weeks

Study Arms (2)

Nanoscopic Partial Meniscectomy

EXPERIMENTAL

This is the experimental group. patients will have a partial meniscectomy performed using the arthrex nanoscope

Procedure: Nanoscopic partial meniscectomy

Standard Partial Meniscectomy

ACTIVE COMPARATOR

Patients will have a partial meniscectomy performed using standard arthroscopic equipment which is the current gold standard

Procedure: Standard Partial Meniscectomy

Interventions

Patients will have a partial meniscectomy performed using the arthrex nanoscope and it will be compared to partial meniscectomy performed using standard arthroscopic equipment

Nanoscopic Partial Meniscectomy

Patients will have partial meniscectomy performed using standard arthroscopic equipment

Standard Partial Meniscectomy

Eligibility Criteria

AgeUp to 65 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • MRI positive for meniscus tear
  • More than 3mm of joint space on PA flexion weightbearing x rays
  • Primary arthroscopy

You may not qualify if:

  • Workers compensation
  • Older than 60 years of age
  • Revision surgeries

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

MedStar Washington Hospital Center

Washington D.C., District of Columbia, 20010, United States

ACTIVE NOT RECRUITING

Marshall Orthopaedics - Teays Valley

Scott Depot, West Virginia, 25560, United States

RECRUITING

Central Study Contacts

Chad Lavender

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 7, 2022

First Posted

November 16, 2022

Study Start

December 1, 2022

Primary Completion

July 1, 2024

Study Completion

December 1, 2024

Last Updated

March 20, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations